Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Recipharm Adds To Its Empire

by Patricia L. Short
January 12, 2009 | A version of this story appeared in Volume 87, Issue 2

The acquisitive Swedish contract development company Recipharm has snapped up Solvay subsidiary Laboratoires Fournier for an undisclosed sum. The purchase gives the Swedish company manufacturing and logistics facilities in Dijon, France, adding to its European operations. Recipharm already has a sterile manufacturing plant in France that it acquired from AstraZeneca in July 2007. At the beginning of this month, Recipharm also wrapped up its acquisition of a majority stake inAstraZeneca Biotech Laboratory, in Sweden.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.